Microsynbiotix Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Microsynbiotix General Information

Description

Developer of cost-effective oral vaccines intended to combat infections and improve global food security. The company's vaccines use microalgae as an oral delivery vehicle to produce effective vaccines that are user-friendly and deliver therapeutic protein orally, thereby enabling farmers to reduce or eliminate the use of antibiotics, reduce fish mortality rates in aquaculture farms and prevent bacterial and viral diseases from wiping out entire fish stocks.

Contact Information

Website
www.microsynbiotix.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 6 Sullivan's Quay
  • Cork T23 XN53
  • Ireland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Sundew
Vertical(s)
AgTech, Supply Chain Tech, TMT, Life Sciences
Corporate Office
  • 6 Sullivan's Quay
  • Cork T23 XN53
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microsynbiotix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Merger/Acquisition 18-Nov-2021 Completed Generating Revenue
9. Early Stage VC 24-Oct-2019 Completed Generating Revenue
8. Early Stage VC 12-May-2019 Completed Generating Revenue
7. Early Stage VC 23-Nov-2018 Completed Generating Revenue
6. Accelerator/Incubator 23-Jul-2018 Completed Generating Revenue
5. Early Stage VC Completed Startup
4. Seed Round 03-Aug-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Startup
2. Grant 01-Jul-2016 $16.9K $100K Completed Startup
1. Accelerator/Incubator 08-Jun-2016 $100K $100K Completed Startup
To view Microsynbiotix’s complete valuation and funding history, request access »

Microsynbiotix Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Microsynbiotix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3455360-A1 Dna constructs for manufacturing bio-therapeutic polypeptides for use in animal vaccines and therapeutics Pending 11-Apr-2016
EP-3455360-A4 Dna constructs for manufacturing bio-therapeutic polypeptides for use in animal vaccines and therapeutics Pending 11-Apr-2016
WO-2017180616-A1 Dna constructs for manufacturing bio-therapeutic polypeptides for use in animal vaccines and therapeutics Inactive 11-Apr-2016
US-10844382-B2 Dna constructs for manufacturing bio-therapuetic polypeptides for use in animal vaccines and therapeutics Active 11-Apr-2016
US-20190142924-A1 Dna constructs for manufacturing bio-therapuetic polypeptides for use in animal vaccines and therapeutics Active 11-Apr-2016 A61K39/12
To view Microsynbiotix’s complete patent history, request access »

Microsynbiotix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microsynbiotix Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alimentos Ventures Venture Capital Minority
Australian Government (Landing Pads) Government
California Life Sciences Accelerator/Incubator Minority
Enterprise Ireland Growth/Expansion Minority
RebelBio Accelerator/Incubator Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Microsynbiotix FAQs

  • When was Microsynbiotix founded?

    Microsynbiotix was founded in 2016.

  • Where is Microsynbiotix headquartered?

    Microsynbiotix is headquartered in Cork, Ireland.

  • What is the size of Microsynbiotix?

    Microsynbiotix has 3 total employees.

  • What industry is Microsynbiotix in?

    Microsynbiotix’s primary industry is Drug Discovery.

  • Is Microsynbiotix a private or public company?

    Microsynbiotix is a Private company.

  • What is Microsynbiotix’s current revenue?

    The current revenue for Microsynbiotix is .

  • How much funding has Microsynbiotix raised over time?

    Microsynbiotix has raised $2.05M.

  • Who are Microsynbiotix’s investors?

    Alimentos Ventures, Australian Government (Landing Pads), California Life Sciences, Enterprise Ireland, and RebelBio are 5 of 8 investors who have invested in Microsynbiotix.

  • When was Microsynbiotix acquired?

    Microsynbiotix was acquired on 18-Nov-2021.

  • Who acquired Microsynbiotix?

    Microsynbiotix was acquired by Sundew.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process